Scientists from WMG at the University of Warwick, led by Eindhoven University of Technology in the Netherlands, developed a 1cm by 1cm wireless artificial aquatic polyp, which can remove contaminants from water. Apart from cleaning, this soft robot could be also used in medical diagnostic devices by aiding in picking up and transporting specific cells for analysis.
A new method for engineering living materials called ‘MeniFluidics’, made by researchers at the University of Warwick could see a transformation in tissue engineering and bio-art, as well as new ways to research cellular interactions.
Midlands Medictech company Medherant in partnership to develop multiple new products with tech developed at University of Warwick
Midlands Medictech company Medherant has just this month (May 2020) signed a partnership agreement with Cambridge based Cycle Pharmaceuticals to develop multiple new products using Medherant technology developed by University of Warwick chemistry researchers. Coventry based Medherant’s TEPI Patch® Technology uses transdermal delivery technology (a patch that can simply be applied to the skin) and medicines for rare diseases combine to deliver significant quality-of-life benefits for patients.
Verdel Instruments Limited (Verdel) has recently announced the close of its £1 million equity funding round from Longwall Ventures.
Verdel is a UK-based company pushing the boundaries of complex sample analysis using innovative Two-Dimensional Mass Spectrometry (2DMS) technology. The approach was originally developed for large, complex FT-ICR instruments, but Verdel has developed technology that transfers the technique onto commonly used, high throughput linear ion trap instruments. Verdel’s technology is based on research by Professor Peter O’Connor at the University of Warwick.